ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could regrow hair in balding men
Disease control Not yet recruitingThis study tests whether a daily oral minoxidil pill (N1087) can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo for 24 weeks, with the dose slowly increased. The main goal is to see if…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New DA-001 hair loss treatment heads to Large-Scale trial
Disease control Not yet recruitingThis study tests whether a treatment called DA-001 can safely reduce hair shedding and promote regrowth in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment as directed and be monit…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE2, PHASE3 • Sponsor: Applied Biology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
One shot to stop balding? new trial tests fat injections against daily cream
Disease control Not yet recruitingThis study tests whether a single injection of nanofat (processed fat from your own body) can treat pattern hair loss better than standard options. Sixty adults with androgenetic alopecia will receive either one nanofat injection, three monthly PRP injections, or daily topical mi…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hair loss drug combo enters human trials
Disease control Not yet recruitingThis early-stage study tests two forms of a hair loss drug (AD-303A topical and AD-3031 oral) in 30 men aged 19-55 with male pattern baldness. The goal is to see how the drug moves through the body, how well it works, and if it is safe. The study will help decide the right dose f…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Moogene Medi Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could amniotic fluid injections regrow hair? new trial begins
Disease control Not yet recruitingThis study tests whether an injection called XVIE, made from processed human amniotic fluid, is safe and might help regrow hair in adults with common pattern baldness. Thirty participants will receive either XVIE or a placebo injected into the scalp, with two treatments 90 days a…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Restore Biologics Holdings, Inc. dba Xtressé • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can stem cell exosomes boost laser hair regrowth? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether adding a stem-cell-derived exosome solution to fractional laser therapy helps regrow hair better than laser alone. Thirty men with male pattern baldness will receive three laser sessions and be followed for six months. Researchers will measure changes in …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
AI could spot hair loss patterns with precision
Diagnosis Not yet recruitingThis study aims to train and test artificial intelligence (AI) models to diagnose male and female pattern hair loss (androgenetic alopecia) and assess its severity. Researchers will use images from a handheld dermoscope along with age and sex data from 400 participants. The goal …
Matched conditions: ANDROGENETIC ALOPECIA
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jun 27, 2026 11:04 UTC